Predictors of prolonged length of hospital stay and in-hospital mortality among adult patients admitted at the surgical ward of Jimma University medical center, Ethiopia: prospective observational study.

Ethiopia In-hospital mortality Predictors Prolonged length of hospital stay Surgery

Journal

Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192

Informations de publication

Date de publication:
2020
Historique:
received: 09 12 2019
accepted: 22 05 2020
entrez: 19 6 2020
pubmed: 19 6 2020
medline: 19 6 2020
Statut: epublish

Résumé

Data regarding prolonged length of hospital stay (PLOS) and in-hospital mortality are paramount to evaluate efficiency and quality of surgical care as well as for rational resource utilization, allocation, and administration. Thus, PLOS and in-hospital mortality have been used as a surrogate indicator of satisfactory treatment outcome and efficient utilization of resources for a given health institution. However, there was a scarcity of data regarding these issues in Ethiopia. Therefore, this study aimed to assess treatment outcome, length of hospital stay, in-hospital mortality, and their determinants. Health facility-based prospective observational study was used for three consecutive months among adult patients hospitalized for the surgical case. Socio-demographic, clinical history, medication history, in-hospital complications, and overall treatment outcomes were collected from the medical charts' of the patients, using a checklist from the day of admission to discharge. PLOS is defined as hospital stay > 75th percentile (≥33 days for the current study). To identify predictor variables for both PLOS and in-hospital mortality, multivariate logistic regression was performed at Of 269 study participants, 91.8% were improved and discharged. PLOS was recorded in 25.3%; at least 33 days of hospital stay. Overall in-hospital mortality was 4.8%; which is equal to an incidence rate of 0.00193 per person-days, 5.2% in-hospital sepsis, and 2.6% of Hospital-acquired pneumonia (HAP), during their hospital stay. After adjusting for other factors; female gender ( In-hospital mortality rate was almost comparable to reports from developing countries, though it was higher than the developed countries. However, the length of hospital stay was extremely higher than that of reports from other parts of the world. Besides, different socio-demographic, health facility's and patients' clinical conditions (baseline and in-hospital complications) were identified as independent predictors for both in-hospital mortality and PLOS. Therefore, the clinician and stakeholders have to emphasize to avoid the modifiable factors to reduce in-hospital mortality and PLOS in the study area; to improve the quality of surgical care.

Sections du résumé

BACKGROUND BACKGROUND
Data regarding prolonged length of hospital stay (PLOS) and in-hospital mortality are paramount to evaluate efficiency and quality of surgical care as well as for rational resource utilization, allocation, and administration. Thus, PLOS and in-hospital mortality have been used as a surrogate indicator of satisfactory treatment outcome and efficient utilization of resources for a given health institution. However, there was a scarcity of data regarding these issues in Ethiopia. Therefore, this study aimed to assess treatment outcome, length of hospital stay, in-hospital mortality, and their determinants.
METHODS METHODS
Health facility-based prospective observational study was used for three consecutive months among adult patients hospitalized for the surgical case. Socio-demographic, clinical history, medication history, in-hospital complications, and overall treatment outcomes were collected from the medical charts' of the patients, using a checklist from the day of admission to discharge. PLOS is defined as hospital stay > 75th percentile (≥33 days for the current study). To identify predictor variables for both PLOS and in-hospital mortality, multivariate logistic regression was performed at
RESULTS RESULTS
Of 269 study participants, 91.8% were improved and discharged. PLOS was recorded in 25.3%; at least 33 days of hospital stay. Overall in-hospital mortality was 4.8%; which is equal to an incidence rate of 0.00193 per person-days, 5.2% in-hospital sepsis, and 2.6% of Hospital-acquired pneumonia (HAP), during their hospital stay. After adjusting for other factors; female gender (
CONCLUSION CONCLUSIONS
In-hospital mortality rate was almost comparable to reports from developing countries, though it was higher than the developed countries. However, the length of hospital stay was extremely higher than that of reports from other parts of the world. Besides, different socio-demographic, health facility's and patients' clinical conditions (baseline and in-hospital complications) were identified as independent predictors for both in-hospital mortality and PLOS. Therefore, the clinician and stakeholders have to emphasize to avoid the modifiable factors to reduce in-hospital mortality and PLOS in the study area; to improve the quality of surgical care.

Identifiants

pubmed: 32549990
doi: 10.1186/s40545-020-00230-6
pii: 230
pmc: PMC7296702
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Ann Surg. 2006 Apr;243(4):547-52
pubmed: 16552208
Indian J Anaesth. 2019 May;63(5):338-349
pubmed: 31142876
Lancet. 2018 Apr 21;391(10130):1589-1598
pubmed: 29306587
PLoS One. 2019 May 17;14(5):e0216770
pubmed: 31100088
Vasa. 2002 Nov;31(4):265-8
pubmed: 12510552
Lancet. 2008 Jul 12;372(9633):139-44
pubmed: 18582931
World J Surg. 2017 Dec;41(12):3038-3045
pubmed: 29030677
Circulation. 2005 Aug 30;112(9 Suppl):I323-7
pubmed: 16159840
Neurosurg Focus. 2015 Dec;39(6):E12
pubmed: 26621410
J Am Coll Surg. 2006 Dec;203(6):865-77
pubmed: 17116555
Rev Bras Anestesiol. 2018 Sep - Oct;68(5):492-498
pubmed: 29776670
J Thorac Cardiovasc Surg. 2007 Feb;133(2):325-32
pubmed: 17258556
Antimicrob Agents Chemother. 2011 Oct;55(10):4659-63
pubmed: 21825293
J Clin Anesth. 2018 May;46:85-90
pubmed: 29427974
Ethiop Med J. 2009 Jan;47(2):135-42
pubmed: 19743793
Ann Thorac Surg. 2000 Oct;70(4):1212-8
pubmed: 11081873
Crit Care. 2005;9(6):R662-9
pubmed: 16280065
Arch Surg. 2005 Mar;140(3):278-83, discussion 284
pubmed: 15781793
PLoS One. 2018 Nov 8;13(11):e0207203
pubmed: 30408118
World J Emerg Surg. 2014 Jul 07;9:43
pubmed: 25050133
Br J Clin Pharmacol. 2000 Apr;49(4):353-62
pubmed: 10759691
JAMA Surg. 2014 Aug;149(8):815-20
pubmed: 25074418
BMC Health Serv Res. 2018 Jan 5;18(1):5
pubmed: 29304787

Auteurs

Gosaye Mekonen Tefera (GM)

Department of Pharmacy, Clinical Pharmacy Unit, Ambo University, Ambo, Ethiopia.

Beshadu Bedada Feyisa (BB)

Department of Public Health, Nutrition Course Unit, Ambo University, Ambo, Ethiopia.

Gurmu Tesfaye Umeta (GT)

Department of Pharmacy, Clinical Pharmacy Unit, Ambo University, Ambo, Ethiopia.

Tsegaye Melaku Kebede (TM)

School of Pharmacy, Department of Clinical Pharmacy, Jimma University, Jimma, Ethiopia.

Classifications MeSH